Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2026.0056
{"title":"Change to Open Access.","authors":"","doi":"10.1001/jamadermatol.2026.0056","DOIUrl":"https://doi.org/10.1001/jamadermatol.2026.0056","url":null,"abstract":"","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":"162 2","pages":"214"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146219673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.4849
Katelin R Ross, Elijah Horesh, Alex G Ortega-Loayza
{"title":"A Nonhealing Ulceration of the Hand.","authors":"Katelin R Ross, Elijah Horesh, Alex G Ortega-Loayza","doi":"10.1001/jamadermatol.2025.4849","DOIUrl":"10.1001/jamadermatol.2025.4849","url":null,"abstract":"","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"196-197"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.4630
Jennifer Strong, Yoshine Saito, Winnie Trang, Andrea Beri, Alexandra Firek, Steven Mario Munoz, Dennis D Hickstein, Steven Z Pavletic, Richard W Childs, Dimana Dimitrova, Jennifer A Kanakry, Christopher G Kanakry, Edward W Cowen, Leslie Castelo-Soccio, Isaac Brownell
{"title":"Demodicosis and Ivermectin-Associated Mazzotti-Like Reactions After Hematopoietic Cell Transplant.","authors":"Jennifer Strong, Yoshine Saito, Winnie Trang, Andrea Beri, Alexandra Firek, Steven Mario Munoz, Dennis D Hickstein, Steven Z Pavletic, Richard W Childs, Dimana Dimitrova, Jennifer A Kanakry, Christopher G Kanakry, Edward W Cowen, Leslie Castelo-Soccio, Isaac Brownell","doi":"10.1001/jamadermatol.2025.4630","DOIUrl":"10.1001/jamadermatol.2025.4630","url":null,"abstract":"","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"203-205"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12676477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.5268
Debby Cheng, Nora Bensellam, Katherine Sanchez, Aurore D Zhang, Ursula Biba, Sherry Ershadi, Samantha Gregoire, Nikki Zangenah, Lorena A Acevedo-Fontanez, Anne Fladger, Nicholas Theodosakis, Arash Mostaghimi, John S Barbieri
<p><strong>Importance: </strong>Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. Misclassification can be associated with biased epidemiologic estimates and misleading conclusions in population-based studies.</p><p><strong>Objective: </strong>To systematically identify and evaluate validated classification approaches for dermatologic conditions using ICD codes in US-based administrative, claims, or electronic health record data.</p><p><strong>Evidence review: </strong>A systematic review was conducted that was registered with PROSPERO (CRD420250654233) and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A comprehensive search of Ovid MEDLINE, Embase, Web of Science, and CINAHL was conducted for studies published from January 1, 2000, to October 21, 2025. The data were analyzed in October 2025. Eligible studies evaluated International Classification of Diseases, Ninth Revision (ICD-9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes used to identify dermatologic conditions in US-based datasets and reported at least 1 classification metric (eg, positive predictive value). To minimize selection and extraction bias, all screening and data extraction were performed independently by 2 reviewers, with discrepancies resolved by consensus.</p><p><strong>Findings: </strong>A total of 59 studies met inclusion criteria. Most reported positive predictive value, with few reporting sensitivity or specificity. Classification accuracy varied widely by condition and coding strategy. Studies included inflammatory and autoimmune conditions (eg, acne vulgaris, perioral dermatitis, psoriasis, palmoplantar pustulosis, hidradenitis suppurativa, atopic dermatitis, prurigo nodularis, dermatomyositis, cutaneous lupus erythematosus, pyoderma gangrenosum, cutaneous sarcoidosis, pemphigus, pemphigoid, granuloma annulare, alopecia areata, and vitiligo), actinic keratosis and skin cancer, pigmentary and hair disorders (eg, androgenic alopecia, cicatricial alopecia, lichen planopilaris, and melasma), drug reactions (eg, Stevens-Johnson syndrome, toxic epidermal necrolysis), and infections (eg, herpes zoster, herpes simplex virus, and cellulitis or abscess). Classification algorithms that incorporated 2 or more codes, dermatologist attribution, or treatment/procedural data often achieved the highest accuracy. Conditions lacking validated algorithms included seborrheic dermatitis, rosacea, fungal infections, and specific alopecia subtypes.</p><p><strong>Conclusions and relevance: </strong>This systematic review provides a summary of the most accurate classification approaches to identify various dermatologic conditions in large administrative datasets. These results may inform study designs when using these datasets. In addition, some com
重要性：使用国际疾病分类（ICD）代码对皮肤病进行准确分类对于使用大型管理数据集的研究至关重要。在基于人群的研究中，错误分类可能与有偏见的流行病学估计和误导性结论有关。目的：系统地识别和评估在美国行政、索赔或电子健康记录数据中使用ICD代码的皮肤疾病的有效分类方法。证据回顾：系统回顾已在PROSPERO注册（CRD420250654233），并根据系统回顾和荟萃分析指南的首选报告项目进行报告。对2000年1月1日至2025年10月21日期间发表的研究进行了Ovid MEDLINE、Embase、Web of Science和CINAHL的综合检索。这些数据是在2025年10月进行分析的。符合条件的研究评估了用于识别美国数据集中皮肤病的国际疾病分类第九版（ICD-9）或国际疾病和相关健康问题统计分类第十版（ICD-10）代码，并报告了至少1个分类指标（例如，阳性预测值）。为了尽量减少选择和提取的偏倚，所有筛选和数据提取均由2位审稿人独立完成，差异通过共识解决。结果：共有59项研究符合纳入标准。大多数报告阳性预测值，很少报告敏感性或特异性。分类精度因条件和编码策略的不同而有很大差异。研究包括炎症和自身免疫性疾病（如：寻常痤疮、口周皮炎、银屑病、掌跖脓肿、化脓性汗腺炎、特应性皮炎、结节性痒疹、皮肌炎、皮肤红斑狼疮、坏疽性脓皮病、皮肤结节病、天疱疮、类天疱疮、环状肉芽肿、斑秃和白癜风）、光化性角化病和皮肤癌、色素和头发疾病(如：雄激素性脱发、瘢痕性脱发、扁平苔藓、和黄褐斑)、药物反应（如史蒂文斯-约翰逊综合征、中毒性表皮坏死松解）和感染（如带状疱疹、单纯疱疹病毒、蜂窝织炎或脓肿）。包含2个或更多代码、皮肤科医生归因或治疗/程序数据的分类算法通常达到最高的准确性。缺乏有效算法的条件包括脂溢性皮炎、酒渣鼻、真菌感染和特定的脱发亚型。结论和相关性：本系统综述总结了在大型管理数据集中识别各种皮肤病的最准确分类方法。当使用这些数据集时，这些结果可以为研究设计提供信息。此外，一些常见情况缺乏经过验证的分类方法，这突出了未来研究的重要领域。随着行政和电子健康记录数据越来越多地支持皮肤病学研究，使用严格验证的算法对于产生可信的发现至关重要。
{"title":"Validation of International Classification of Diseases Codes for Dermatologic Conditions: A Systematic Review.","authors":"Debby Cheng, Nora Bensellam, Katherine Sanchez, Aurore D Zhang, Ursula Biba, Sherry Ershadi, Samantha Gregoire, Nikki Zangenah, Lorena A Acevedo-Fontanez, Anne Fladger, Nicholas Theodosakis, Arash Mostaghimi, John S Barbieri","doi":"10.1001/jamadermatol.2025.5268","DOIUrl":"10.1001/jamadermatol.2025.5268","url":null,"abstract":"<p><strong>Importance: </strong>Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. Misclassification can be associated with biased epidemiologic estimates and misleading conclusions in population-based studies.</p><p><strong>Objective: </strong>To systematically identify and evaluate validated classification approaches for dermatologic conditions using ICD codes in US-based administrative, claims, or electronic health record data.</p><p><strong>Evidence review: </strong>A systematic review was conducted that was registered with PROSPERO (CRD420250654233) and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A comprehensive search of Ovid MEDLINE, Embase, Web of Science, and CINAHL was conducted for studies published from January 1, 2000, to October 21, 2025. The data were analyzed in October 2025. Eligible studies evaluated International Classification of Diseases, Ninth Revision (ICD-9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes used to identify dermatologic conditions in US-based datasets and reported at least 1 classification metric (eg, positive predictive value). To minimize selection and extraction bias, all screening and data extraction were performed independently by 2 reviewers, with discrepancies resolved by consensus.</p><p><strong>Findings: </strong>A total of 59 studies met inclusion criteria. Most reported positive predictive value, with few reporting sensitivity or specificity. Classification accuracy varied widely by condition and coding strategy. Studies included inflammatory and autoimmune conditions (eg, acne vulgaris, perioral dermatitis, psoriasis, palmoplantar pustulosis, hidradenitis suppurativa, atopic dermatitis, prurigo nodularis, dermatomyositis, cutaneous lupus erythematosus, pyoderma gangrenosum, cutaneous sarcoidosis, pemphigus, pemphigoid, granuloma annulare, alopecia areata, and vitiligo), actinic keratosis and skin cancer, pigmentary and hair disorders (eg, androgenic alopecia, cicatricial alopecia, lichen planopilaris, and melasma), drug reactions (eg, Stevens-Johnson syndrome, toxic epidermal necrolysis), and infections (eg, herpes zoster, herpes simplex virus, and cellulitis or abscess). Classification algorithms that incorporated 2 or more codes, dermatologist attribution, or treatment/procedural data often achieved the highest accuracy. Conditions lacking validated algorithms included seborrheic dermatitis, rosacea, fungal infections, and specific alopecia subtypes.</p><p><strong>Conclusions and relevance: </strong>This systematic review provides a summary of the most accurate classification approaches to identify various dermatologic conditions in large administrative datasets. These results may inform study designs when using these datasets. In addition, some com","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"181-191"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.4606
Rafael Fayos-Gregori, Miguel Mansilla-Polo, Gonzalo Alonso-Fernández, Daniel Martín-Torregrosa, Ignacio Torres-Navarro
{"title":"Successful Treatment of Refractory Severe Localized Scleroderma With Anifrolumab.","authors":"Rafael Fayos-Gregori, Miguel Mansilla-Polo, Gonzalo Alonso-Fernández, Daniel Martín-Torregrosa, Ignacio Torres-Navarro","doi":"10.1001/jamadermatol.2025.4606","DOIUrl":"10.1001/jamadermatol.2025.4606","url":null,"abstract":"","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"210-212"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.4318
Sarah T Arron, Afton Cobb, Lilia M Correa-Selm, Katherine M Given, Manu Jain, David Pilkington, Jennifer Y Wang, Michael Z Wang
<p><strong>Importance: </strong>Histopathology with light microscopy is the reference standard for cellular evaluation of solid tissue, but whether noninvasive cross-modal imaging of skin provides clinicians with comparable histologic information that may assist in clinical decision-making is not well known.</p><p><strong>Objective: </strong>To evaluate safety and effectiveness of cross-modal imaging in obtaining in vivo images, to demonstrate that images align with corresponding skin histopathology, and to evaluate the ability of blinded readers to accurately identify tissue features on cross-modal images.</p><p><strong>Design, setting, and participants: </strong>This observational diagnostic study included 1 visit and follow-up call. Eligible participants were adults aged 18 to 99 years seen for routine care in the outpatient dermatology setting with an indication for lesional skin biopsy. The study was conducted from October 20, 2022, to August 11, 2023, at 2 outpatient dermatology clinics in the US. Cross-modal images and skin biopsy were collected from 1 lesion per participant. Participants were randomized to training (40%) and validation sets (60%). Comparative readers used the training set to evaluate cross-modal images against hematoxylin and eosin histopathology to validate tissue features and train blinded physician readers. Comparative readers developed a performance test with the validation set; blinded physician readers were tested on cross-modal feature identification without access to other participant data.</p><p><strong>Exposure: </strong>All participants underwent cross-modal imaging before biopsy.</p><p><strong>Main outcomes and measures: </strong>The primary end points were 100% comparative reader agreement and validation of cross-modal image tissue features against histopathology and 90% or greater accuracy of blinded physician readers identification of primary tissue features against comparative reader annotation. Secondary end points included accuracy of blinded physician reader identification of secondary features and greater than 90% interrater agreement between blinded physician readers. The safety end point was the number of adverse events observed.</p><p><strong>Results: </strong>A total of 65 participants (median age, 69 [range 20-93] years; 41.5% female and 58.5% male; 1.5% American Indian or Alaska Native; 13.8% Hispanic or Latino; 86.2% not Hispanic or Latino; 98.5% White) underwent cross-modal imaging. Comparative readers achieved 100% consensus and validation of cross-modal histologic features compared with histopathology. Blinded physician reader accuracy for primary histologic features was 96.4% (95% CI, 94.2%-98.7%) and for secondary histologic features was 98.5% (95% CI, 98.1%-98.9%). Interrater agreement among the blinded physician readers was high (Fleiss κ: region, 0.94 [95% CI, 0.87-1.0]; feature, 0.93 [95% CI, 0.88-0.97]). No adverse events were reported.</p><p><strong>Conclusions and relevance: </strong
{"title":"Cross-Modal Imaging in Noninvasive Identification of Histologic Features of Skin.","authors":"Sarah T Arron, Afton Cobb, Lilia M Correa-Selm, Katherine M Given, Manu Jain, David Pilkington, Jennifer Y Wang, Michael Z Wang","doi":"10.1001/jamadermatol.2025.4318","DOIUrl":"10.1001/jamadermatol.2025.4318","url":null,"abstract":"<p><strong>Importance: </strong>Histopathology with light microscopy is the reference standard for cellular evaluation of solid tissue, but whether noninvasive cross-modal imaging of skin provides clinicians with comparable histologic information that may assist in clinical decision-making is not well known.</p><p><strong>Objective: </strong>To evaluate safety and effectiveness of cross-modal imaging in obtaining in vivo images, to demonstrate that images align with corresponding skin histopathology, and to evaluate the ability of blinded readers to accurately identify tissue features on cross-modal images.</p><p><strong>Design, setting, and participants: </strong>This observational diagnostic study included 1 visit and follow-up call. Eligible participants were adults aged 18 to 99 years seen for routine care in the outpatient dermatology setting with an indication for lesional skin biopsy. The study was conducted from October 20, 2022, to August 11, 2023, at 2 outpatient dermatology clinics in the US. Cross-modal images and skin biopsy were collected from 1 lesion per participant. Participants were randomized to training (40%) and validation sets (60%). Comparative readers used the training set to evaluate cross-modal images against hematoxylin and eosin histopathology to validate tissue features and train blinded physician readers. Comparative readers developed a performance test with the validation set; blinded physician readers were tested on cross-modal feature identification without access to other participant data.</p><p><strong>Exposure: </strong>All participants underwent cross-modal imaging before biopsy.</p><p><strong>Main outcomes and measures: </strong>The primary end points were 100% comparative reader agreement and validation of cross-modal image tissue features against histopathology and 90% or greater accuracy of blinded physician readers identification of primary tissue features against comparative reader annotation. Secondary end points included accuracy of blinded physician reader identification of secondary features and greater than 90% interrater agreement between blinded physician readers. The safety end point was the number of adverse events observed.</p><p><strong>Results: </strong>A total of 65 participants (median age, 69 [range 20-93] years; 41.5% female and 58.5% male; 1.5% American Indian or Alaska Native; 13.8% Hispanic or Latino; 86.2% not Hispanic or Latino; 98.5% White) underwent cross-modal imaging. Comparative readers achieved 100% consensus and validation of cross-modal histologic features compared with histopathology. Blinded physician reader accuracy for primary histologic features was 96.4% (95% CI, 94.2%-98.7%) and for secondary histologic features was 98.5% (95% CI, 98.1%-98.9%). Interrater agreement among the blinded physician readers was high (Fleiss κ: region, 0.94 [95% CI, 0.87-1.0]; feature, 0.93 [95% CI, 0.88-0.97]). No adverse events were reported.</p><p><strong>Conclusions and relevance: </strong","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"115-123"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12590393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1001/jamadermatol.2025.5112
Yanel Hernandez, Nathaly Gonzalez, Raveena Ghanshani, Herbert B Castillo Valladares, Erin H Amerson, Haley B Naik, Jennifer L Hsiao, Jennifer James, Sara L Ackerman, Aileen Y Chang
Importance: Latine patients with hidradenitis suppurativa (HS) are reported to experience more severe disease and longer delays to diagnosis compared with White patients with HS.
Objective: To assess the implications of health care system factors in HS care experiences for Latine patients.
Design, setting, and participants: From June 2024 through March 2025, this qualitative study recruited English- and Spanish-language preferring Latine adults diagnosed with HS from dermatology clinics at 2 academic medical centers and 2 county hospitals in California. Deidentified audio recordings were transcribed and translated from semistructured interviews conducted by a bilingual Latine interviewer.
Main outcomes and measures: After transcripts were coded, a thematic analysis was conducted to develop themes that captured the range of participants' experiences, attitudes, behaviors, and beliefs related to receiving health care for HS and implementing HS care plans throughout their HS care journey, including the time before they received care from their current dermatologist.
Results: Among the 24 Latine patients included in the analysis, the median (IQR) age was 37.5 (32.75-44.25) years, 17 (71%) were female, 11 (46%) preferred Spanish, and 19 (79%) had Hurley stage 2 or 3 disease. Three themes were developed. First, unaddressed wound care and pain management burdens patients with self-directed care, with 2 subthemes: (1) insufficient guidance for patients' wound care and pain management and (2) self-directed care in response to limited health care system support for pain management and wound care creates personal burden. Second, perceived discrimination during dermatology visits leads to avoidance of care. Third, patient-centered care remains a challenge with phone or video interpreter-mediated communication.
Conclusions and relevance: In this study, many Latine participants with HS experienced unaddressed wound care and pain management needs, perceived discrimination, and challenges with interpreter-mediated communication during care with a dermatologist. Interventions are needed to prioritize wound care and pain management in multidisciplinary care plans and optimize patient-centered HS care.
{"title":"Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa.","authors":"Yanel Hernandez, Nathaly Gonzalez, Raveena Ghanshani, Herbert B Castillo Valladares, Erin H Amerson, Haley B Naik, Jennifer L Hsiao, Jennifer James, Sara L Ackerman, Aileen Y Chang","doi":"10.1001/jamadermatol.2025.5112","DOIUrl":"10.1001/jamadermatol.2025.5112","url":null,"abstract":"<p><strong>Importance: </strong>Latine patients with hidradenitis suppurativa (HS) are reported to experience more severe disease and longer delays to diagnosis compared with White patients with HS.</p><p><strong>Objective: </strong>To assess the implications of health care system factors in HS care experiences for Latine patients.</p><p><strong>Design, setting, and participants: </strong>From June 2024 through March 2025, this qualitative study recruited English- and Spanish-language preferring Latine adults diagnosed with HS from dermatology clinics at 2 academic medical centers and 2 county hospitals in California. Deidentified audio recordings were transcribed and translated from semistructured interviews conducted by a bilingual Latine interviewer.</p><p><strong>Main outcomes and measures: </strong>After transcripts were coded, a thematic analysis was conducted to develop themes that captured the range of participants' experiences, attitudes, behaviors, and beliefs related to receiving health care for HS and implementing HS care plans throughout their HS care journey, including the time before they received care from their current dermatologist.</p><p><strong>Results: </strong>Among the 24 Latine patients included in the analysis, the median (IQR) age was 37.5 (32.75-44.25) years, 17 (71%) were female, 11 (46%) preferred Spanish, and 19 (79%) had Hurley stage 2 or 3 disease. Three themes were developed. First, unaddressed wound care and pain management burdens patients with self-directed care, with 2 subthemes: (1) insufficient guidance for patients' wound care and pain management and (2) self-directed care in response to limited health care system support for pain management and wound care creates personal burden. Second, perceived discrimination during dermatology visits leads to avoidance of care. Third, patient-centered care remains a challenge with phone or video interpreter-mediated communication.</p><p><strong>Conclusions and relevance: </strong>In this study, many Latine participants with HS experienced unaddressed wound care and pain management needs, perceived discrimination, and challenges with interpreter-mediated communication during care with a dermatologist. Interventions are needed to prioritize wound care and pain management in multidisciplinary care plans and optimize patient-centered HS care.</p>","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"151-156"},"PeriodicalIF":11.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12728727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-28DOI: 10.1001/jamadermatol.2025.6203
{"title":"Errors in Byline and Figures 3 and 4.","authors":"","doi":"10.1001/jamadermatol.2025.6203","DOIUrl":"10.1001/jamadermatol.2025.6203","url":null,"abstract":"","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146063428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：